1. AbbVie Investors Agitate for Chair-CEO Split, Flagging Bonus Pay and Humira Hikes

    Pharma News BoardNews
    AbbVie Investors Agitate for Chair-CEO Split, Flagging Bonus Pay and Humira Hikes

    The call by investors comes on the heels of CEO Richard Gonzalez's grilling over his bonus pay by members of the Senate Finance Committee. (AbbVie) AbbVie investors are calling for a separation of powers in the C-suite, citing Chairman and CEO Richard Gonzalez's outsized pay package and the company's "thicket" of Humira patents...

    Read Full Article

    Login to comment.

    Related Articles

  1. Search:

  2. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Partner Publications, Question of The Week, Sponsored Content

  3. Quotes

    1. Shareholders would benefit from the leadership and governance of an Independent Chair.
    2. Since the 2018 annual shareholder meeting, share value of our company has continued to decline, and the company is facing mounting legal and reputational risks related to its management of patents and unsustainable pricing of Humira.

  4. Topics Mentioned